Cargando…
Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies
Adenosine is a potent immunosuppressive metabolite that accumulates in the extracellular space within solid tumors and inhibits the antitumor function of native immune cell responses as well as chimeric antigen receptor (CAR) T-cell therapies. Here, we show that engineered human cells can degrade ex...
Autores principales: | Cox, J.R., Jennings, M., Lenahan, C., Manion, M., Courville, S., Blazeck, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374970/ https://www.ncbi.nlm.nih.gov/pubmed/37519414 http://dx.doi.org/10.1016/j.iotech.2023.100394 |
Ejemplares similares
-
Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer
por: Zhulai, Galina, et al.
Publicado: (2022) -
Early Enzyme Replacement Therapy Improves Hearing and Immune Defects in Adenosine Deaminase Deficient-Mice
por: Xu, Xiaobai, et al.
Publicado: (2019) -
Adenosine deaminases acting on RNA (ADARs): RNA-editing enzymes
por: Keegan, Liam P, et al.
Publicado: (2004) -
Adenosine deaminase activity in leukaemia.
por: Smyth, J. F., et al.
Publicado: (1975) -
Inhibition of maturation of human precursor lymphocytes by coformycin, and inhibitor of the enzyme adenosine deaminase
por: Ballet, J, et al.
Publicado: (1976)